2026 NPPES data Critical Care Medicine (Internal Medicine) Physician NPI 1962679266 MD
Verify on CMS →

LUSINE MELIK-ADAMYAN, MD

Critical Care Medicine (Internal Medicine) Physician in LOS ALAMITOS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 178 beneficiaries · Critical Care Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
43%
generic claims · 57% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
61.5143/100
▼ 22 pts below national avg 83.1 · [object Object]
Industry payments
$141.39
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LUSINE MELIK-ADAMYAN, MD reported a CMS MIPS final score of 61.5143/100 — below the 83.1 national average — and filed 1,120 Medicare Part D claims in 2023.

61.5143/100
MIPS score · -22 vs avg
1K
Part D claims, 2023
43%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LUSINE MELIK-ADAMYAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

62 6th percentile higher than 6% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

LUSINE MELIK-ADAMYAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LUSINE MELIK-ADAMYAN, MD?

Below national average

NPI registry status

Active

Issued 05/15/2008

NPI 1962679266

Primary specialty

Critical Care Medicine (Internal Medicine) Physician

Mid-sized

6,631 US NPIs in this specialty

Medicare Part D claims

1,120 5% vs specialty avg

2023 prescription claims

Specialty avg: 1,069

MIPS final score

61.5143/100 21.585699999999996% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Critical Care Medicine (Internal Medicine) Physician compares to other specialties among California providers

California providers

Critical Care Medicine (Internal Medicine) Physician share within California

1. Critical Care Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Critical Care Medicine (Internal Medicine) Physician share within California

Medicare quality performance — MIPS

LUSINE MELIK-ADAMYAN, MD's 2023 MIPS final score plotted against the Critical Care Medicine (Internal Medicine) Physician national average

Below national average
MIPS Final Score
61.5143/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Critical Care Medicine (Internal Medicine) Physician) — 61.5143/100 vs national avg 83.1

0%100%National avg83%61.5%
MIPS final score (Critical Care Medicine (Internal Medicine) Physician) — 61.5143/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LUSINE MELIK-ADAMYAN, MD appears in the CMS NPPES registry as a Critical Care Medicine (Internal Medicine) Physician provider holding MD credentials at 5300 KATELLA AVE, LOS ALAMITOS, CA, 90720, with a listed phone of (562) 445-4443. NPI 1962679266 was issued on 05/15/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MELIK-ADAMYAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,120 prescription claims written by this provider, covering 178 Medicare beneficiaries and totaling roughly $392K in drug spend, split 57% brand-name and 43% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 61.5143/100 for the 2023 performance year (Quality 45.2153, Cost 69.8325), compared with the national average of 83.1.

Critical Care Medicine (Internal Medicine) Physician is a mid-sized specialty nationwide, with 6,631 enrolled providers across 53 states and an average of 1,069 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5300 KATELLA AVE
LOS ALAMITOS, CA 90720

Provider Details

NPI 1962679266
Specialty Critical Care Medicine (Internal Medicine) Physician
Credentials MD
Gender Female
NPI Issued 05/15/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

61.5143
Final Score
Avg: 83.1
45.2153
Quality
69.8325
Cost
28
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LUSINE MELIK-ADAMYAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$141

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LUSINE MELIK-ADAMYAN, MD. To verify LUSINE MELIK-ADAMYAN, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

LUSINE MELIK-ADAMYAN, MD — brand share 57.0%
Specialty average (est.)

57% brand-name claims vs 43% generic, on 1,120 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,120
Total Claims
$392K
Total Drug Cost
178
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,618
Total Day Supply
45,117
Brand vs Generic
57% brand / 43% generic
Brand Drug Cost
$368K
Antibiotic Claims
86

Patient Demographics

Average Patient Age
78.5 years
Avg HCC Risk Score
2.29
Gender Split
67% female / 33% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LUSINE MELIK-ADAMYAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
137
Albuterol Sulfate Hfa
Albuterol Sulfate
130
Montelukast Sodium
125
Prednisone
70
Azithromycin
69
Breo Ellipta
Fluticasone/Vilanterol
67
Symbicort
Budesonide/Formoterol Fumarate
50
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
48
Spiriva Respimat
Tiotropium Bromide
48
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
41

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Critical Care Medicine (Internal Medicine) Physician Overview

How LUSINE MELIK-ADAMYAN, MD fits within the Critical Care Medicine (Internal Medicine) Physician landscape nationally.

6,631
Critical Care Medicine (Internal Medicine) Physician Providers in US
53
States with Critical Care Medicine (Internal Medicine) Physician
1,069
Avg Claims per Provider

LUSINE MELIK-ADAMYAN, MD's 1,120 claims are above the specialty average of 1,069.

Nearby Critical Care Medicine (Internal Medicine) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as MELIK-ADAMYAN.

Compare Critical Care Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LUSINE MELIK-ADAMYAN, MD's specialty?
LUSINE MELIK-ADAMYAN, MD specializes in Critical Care Medicine (Internal Medicine) Physician and practices in LOS ALAMITOS, California. Credentials: MD.
How much does LUSINE MELIK-ADAMYAN, MD prescribe under Medicare Part D?
In 2023, LUSINE MELIK-ADAMYAN, MD wrote 1,120 Medicare Part D claims totaling $392K in drug costs for 178 beneficiaries.
What is LUSINE MELIK-ADAMYAN, MD's Medicare quality score?
LUSINE MELIK-ADAMYAN, MD has a CMS MIPS Final Score of 61.5143/100 (Quality: 45.2153, Cost: 69.8325). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LUSINE MELIK-ADAMYAN, MD located?
LUSINE MELIK-ADAMYAN, MD is located at 5300 KATELLA AVE, LOS ALAMITOS, CA, 90720. Phone: (562) 445-4443.
What is LUSINE MELIK-ADAMYAN, MD's NPI number?
LUSINE MELIK-ADAMYAN, MD's National Provider Identifier (NPI) is 1962679266, issued on 05/15/2008.
Does LUSINE MELIK-ADAMYAN, MD prescribe more brand-name or generic drugs?
LUSINE MELIK-ADAMYAN, MD's prescribing is 57% brand-name and 43% generic drugs by claim count, with $368K in brand drug costs.
How many Critical Care Medicine (Internal Medicine) Physician providers are there in the US?
There are 6,631 Critical Care Medicine (Internal Medicine) Physician providers across 53 states in the US. The average Critical Care Medicine (Internal Medicine) Physician provider writes 1,069 Medicare Part D claims per year.
What drugs does LUSINE MELIK-ADAMYAN, MD prescribe most often?
Based on 2023 Medicare Part D data, LUSINE MELIK-ADAMYAN, MD's most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LUSINE MELIK-ADAMYAN, MD accept Medicare?
LUSINE MELIK-ADAMYAN, MD appears in CMS Medicare data with 1,120 Part D claims and 178 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LUSINE MELIK-ADAMYAN, MD's credentials?
LUSINE MELIK-ADAMYAN, MD's NPI is 1962679266 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology